OBJECTIVE-The hypothalamus is the central brain region responsible for sensing and integrating responses to changes in circulating glucose. The aim of this study was to determine the time sequence relationship between hypothalamic activation and the initiation of the counterregulatory hormonal response to small decrements in systemic glucose.RESEARCH DESIGN AND METHODS-Nine nondiabetic volunteers underwent two hyperinsulinemic clamp sessions in which pulsed arterial spin labeling was used to measure regional cerebral blood flow (CBF) at euglycemia (ϳ95 mg/dl) on one occasion and as glucose levels were declining to a nadir of ϳ50 mg/dl on another occasion. Plasma glucose and counterregulatory hormones were measured during both study sessions.RESULTS-CBF to the hypothalamus significantly increased when glucose levels decreased to 77.2 Ϯ 2 mg/dl compared with the euglycemic control session when glucose levels were 95.7 Ϯ 3 mg/dl (P ϭ 0.0009). Hypothalamic perfusion was significantly increased before there was a significant elevation in counterregulatory hormones.CONCLUSIONS-Our data suggest that the hypothalamus is exquisitely sensitive to small decrements in systemic glucose levels in healthy, nondiabetic subjects and that hypothalamic blood flow, and presumably neuronal activity, precedes the rise in counterregulatory hormones seen during hypoglycemia. Diabetes 58:448-452, 2009 T he brain relies on glucose as its main energy substrate, and small decrements in circulating glucose provoke an elaborate counterregulatory hormonal feedback response (1,2). Activation of the counterregulatory response requires effective detection of a falling glucose level. Although multiple glucose sensors may be involved (3-7), the hypothalamus has emerged as the dominant brain region responsible for sensing and integrating responses to changes in circulating glucose levels (8 -12). Although most prior studies have relied on animal models to study the neurophysiological response to changes in glucose, newer imaging techniques such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) provide an in vivo method to study the effect of changes in peripheral glucose levels on human brain activity. Several fMRI studies in humans have demonstrated that a rise in systemic glucose after glucose ingestion leads to an inhibition of hypothalamic activity (13-16). In addition, Musen et al. (17) recently used fMRI based on the blood oxygenation leveldependent (BOLD) contrast mechanism and found that insulin-induced hypoglycemia leads to hypothalamic activation. However, the fMRI-BOLD approach used in that study assesses only relative changes in oxygenated hemoglobin in specific brain regions and does not directly measure tissue perfusion. Magnetic resonance imaging (MRI) pulsed arterial spin labeling (PASL) provides a method for measuring absolute blood flow responses throughout the brain to changes in circulating glucose levels. PASL magnetically tags the arterial blood before entering the brain and then examines t...